Skip to main content
OpenTrials

Clinical trial condition

Choroidal Neovascularization

Explore clinical trials studying Choroidal Neovascularization. Study availability and eligibility vary by location and protocol.

150 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Choroidal Neovascularization trial results

Completed

Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

NCT02358889

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +9 more
Locations
  • Phoenix, Arizona, United States
  • Phoenix, Arizona, United States
  • Arcadia, California, United States
  • Beverly Hills, California, United States
View all 48 locations
View Trial Details
Completed

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration

NCT03249740

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +9 more
Locations
  • Retinal Consultants of Arizona Gilbert, Arizona, United States
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • Midwest Eye Institute Indianapolis, Indiana, United States
  • Ophthalmic Consultants of Long Island Lynbrook, New York, United States
View Trial Details
Completed

An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.

NCT01908816

Conditions
Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +19 more
Locations
  • Novartis Investigative Site Bobigny, Seine Saint Denis, France
  • Novartis Investigative Site Amiens, France
  • Novartis Investigative Site Angers, France
  • Novartis Investigative Site Bordeaux, France
View all 39 locations
View Trial Details
Completed

Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

NCT01922102

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +6 more
Locations
  • Novartis Investigative Site Beijing, Beijing Municipality, China
  • Novartis Investigative Site Beijing, Beijing Municipality, China
  • Novartis Investigative Site Chongqing, Chongqing Municipality, China
  • Novartis Investigative Site Shantou, Guangdong, China
View all 47 locations
View Trial Details

Related conditions